
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
Selecting a buffer for the formulation of a protein requires an understanding of the potential effects of various buffers on protein stabilization.
over 22 years ago
Pharmaceutical Pricing and Healthcare Accessover 22 years ago
Packaging Helps Protect Temperature-Sensitive Productsover 22 years ago
Resealed Erythrocytes: A Reviewover 22 years ago
Pharma Industry Drives Innovation in Barrier/Isolation Designover 22 years ago
Connecting Clinical Trial Management to Pharmaceutical Manufacturingover 22 years ago
March 2003over 22 years ago
Stakes Getting Higher for Contractors





